A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple‐negative breast cancer-Reference-Cited by-同舟云学术

A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple‐negative breast cancer

Published:2019-11-20 Issue:4 Volume:126 Page:850-860
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ho Alice Y.¹^ORCID,Barker Christopher A.¹,Arnold Brittany B.¹,Powell Simon N.¹,Hu Zishuo I.²,Gucalp Ayca²^ORCID,Lebron‐Zapata Lizza³,Wen Hannah Y.⁴,Kallman Cindy⁵,D'Agnolo Alessandro⁵,Zhang Zhigang⁶,Flynn Jessica⁶,Dunn Samantha A.⁷,McArthur Heather L.⁸

Affiliation:

1. Department of Radiation Oncology Memorial Sloan Kettering Cancer Center New York New York

2. Medical Oncology, Department of Medicine Memorial Sloan Kettering Cancer Center New York New York

3. Department of Radiology Memorial Sloan Kettering Cancer Center New York New York

4. Department of Pathology Memorial Sloan Kettering Cancer Center New York New York

5. Department of Radiology Cedars‐Sinai Medical Center Los Angeles California

6. Department of Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Center New York New York

7. Department of Radiation Oncology Massachusetts General Hospital Boston Massachusetts

8. Medical Oncology, Department of Medicine Cedars‐Sinai Medical Center Los Angeles California

Funder

Merck

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32599

Reference38 articles.

1. Triple-Negative Breast Cancer

2. Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design

3. Sequence analysis of mutations and translocations across breast cancer subtypes

4. PD-L1 Expression in Triple-Negative Breast Cancer

5. Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Pembrolizumab Monotherapy or Combined Therapy in Patients with Metastatic Triple-negative Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Current Gene Therapy;2025-02

2. Evolving immunotherapeutic solutions for triple-negative breast carcinoma;Cancer Treatment Reviews;2024-11

3. Current applications of tumor local ablation (TLA) combined with immune checkpoint inhibitors in breast cancer treatment;Cancer Drug Resistance;2024-09-13

4. Treatment Outcomes after Postoperative Radiotherapy in Triple-Negative Breast Cancer: Multi-Institutional Retrospective Study (KROG 17-05);Journal of Personalized Medicine;2024-09-04

5. The value of intervention with radiotherapy after first-line chemo-immunotherapy in locally advanced or metastatic esophageal squamous cell carcinoma: A multi-center retrospective study;Clinical and Translational Radiation Oncology;2024-09